Skip to content

Comprehensive Segmental Revision System

Degenerative Disease | Oncology | Revision Surgery | Trauma | Rheumatoid Arthritis

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity
* Oncology applications including bone loss due to tumour resection

Exclusion Criteria:

* Sepsis ( active)
* Infection ( active)
* Osteomyelitis (active)

Study Location

Nova Scotia Health Authority
Nova Scotia Health Authority
Halifax, Nova Scotia
Canada

Contact Study Team

Primary Contact

Kelly Trask

Study Sponsored By
Zimmer Biomet
Participants Required
More Information
Study ID: NCT03270982